Chorokbaem Healthcare (Korea) Performance
| 118000 Stock | 310.00 5.00 1.59% |
The firm shows a Beta (market volatility) of 0.0642, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chorokbaem Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chorokbaem Healthcare is expected to be smaller as well. At this point, Chorokbaem Healthcare has a negative expected return of -0.42%. Please make sure to confirm Chorokbaem Healthcare's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Chorokbaem Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Chorokbaem Healthcare Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 14.7 B | |
| Total Cashflows From Investing Activities | 11.9 B |
Chorokbaem |
Chorokbaem Healthcare Relative Risk vs. Return Landscape
If you would invest 40,200 in Chorokbaem Healthcare Co on September 2, 2024 and sell it today you would lose (9,200) from holding Chorokbaem Healthcare Co or give up 22.89% of portfolio value over 90 days. Chorokbaem Healthcare Co is generating negative expected returns and assumes 1.6063% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Chorokbaem, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Chorokbaem Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chorokbaem Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chorokbaem Healthcare Co, and traders can use it to determine the average amount a Chorokbaem Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2611
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 118000 |
Estimated Market Risk
| 1.61 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chorokbaem Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chorokbaem Healthcare by adding Chorokbaem Healthcare to a well-diversified portfolio.
Chorokbaem Healthcare Fundamentals Growth
Chorokbaem Stock prices reflect investors' perceptions of the future prospects and financial health of Chorokbaem Healthcare, and Chorokbaem Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chorokbaem Stock performance.
| Return On Equity | -0.24 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (1.60) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 72.69 B | |||
| Shares Outstanding | 84.7 M | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 2.98 X | |||
| Revenue | 18.61 B | |||
| EBITDA | 16.64 B | |||
| Cash Flow From Operations | (1.49 B) | |||
| Total Asset | 176.3 B | |||
About Chorokbaem Healthcare Performance
By analyzing Chorokbaem Healthcare's fundamental ratios, stakeholders can gain valuable insights into Chorokbaem Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chorokbaem Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chorokbaem Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Chorokbaem Healthcare performance evaluation
Checking the ongoing alerts about Chorokbaem Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chorokbaem Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chorokbaem Healthcare generated a negative expected return over the last 90 days | |
| Chorokbaem Healthcare generates negative cash flow from operations | |
| About 39.0% of the company shares are owned by insiders or employees |
- Analyzing Chorokbaem Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chorokbaem Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Chorokbaem Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chorokbaem Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chorokbaem Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chorokbaem Healthcare's stock. These opinions can provide insight into Chorokbaem Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chorokbaem Stock analysis
When running Chorokbaem Healthcare's price analysis, check to measure Chorokbaem Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chorokbaem Healthcare is operating at the current time. Most of Chorokbaem Healthcare's value examination focuses on studying past and present price action to predict the probability of Chorokbaem Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chorokbaem Healthcare's price. Additionally, you may evaluate how the addition of Chorokbaem Healthcare to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |